| IPI00218252 - TGM2, ISOFORM 3 OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2. | |
|---|---|
| Uniprot Accession: A2A299 | |
| Uniprot ID: A2A299_HUMAN | |
| Mapping: Chr 20, 36190280 - 36227114 | |
| Entrez Gene: 7052 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_4154) |
|---|
| Rat: Tgm2, TRANSGLUTAMINASE 2, C POLYPEPTIDE. |
| Mouse: Tgm2, PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2. |
| Mouse: Tgm2, FULL INSERT SEQUENCE. |
| Mouse: Tgm2, TRANSGLUTAMINASE 2, C POLYPEPTIDE. |
| Human: TGM2, ISOFORM 2 OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2. |
| Human: TGM2, ISOFORM 3 OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2. |
| Human: TGM2, ISOFORM 1 OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cytoplasm | C | ISS | ||
| membrane | C | TAS | ||
| plasma membrane | C | IDA | ||
| cytosol | C | TAS | ||
| proteinaceous extracellular matrix | C | TAS | ||
| mitochondrion | C | IDA | ||
| protein serine/threonine kinase activity | F | ISS | ||
| enzyme binding | F | IC | ||
| metal ion binding | F | IEA | ||
| calcium ion binding | F | NAS | ||
| GTP binding | F | NAS | IDA | |
| acyltransferase activity | F | IEA | ||
| protein domain specific binding | F | IPI | ||
| cysteine-type endopeptidase activity | F | RCA | ISS | |
| transferase activity | F | IEA | ||
| protein-glutamine gamma-glutamyltransferase activity | F | IMP | IDA ISS | |
| positive regulation of cell adhesion | P | IMP | ||
| G-protein coupled receptor protein signaling pathway | P | TAS | ||
| activation of NF-kappaB transcription factor | P | ISS | ||
| elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | P | IMP | ||
| release of cytoplasmic sequestered NF-kappaB | P | ISS | ||
| histone phosphorylation | P | ISS | ||
| induction of apoptosis | P | IDA | ||
| positive regulation of inflammatory response | P | IMP | ||
| isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | P | IDA | ||
| positive regulation of smooth muscle cell proliferation | P | IDA | ||
| positive regulation of I-kappaB kinase/NF-kappaB cascade | P | IMP | ||
| protein homooligomerization | P | IDA IDA | ||
| proteolysis | P | RCA | ISS | |
| blood vessel remodeling | P | IMP | ||
| peptide cross-linking | P | TAS | IEA | |
| histone acetylation | P | ISS | ||
| protein oligomerization | P | ISS | ||
| G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | P | ISS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cellular phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| behavior/neurological phenotype | MP | Un | ||
| immune system phenotype | MP | Un | ||
| nervous system phenotype | MP | Un | ||
| hematopoietic system phenotype | MP | Un | ||
| no phenotypic analysis | MP | Un | ||
| life span-post-weaning/aging | MP | Un | ||
| abnormal apoptosis | N | ISS | ||
| dilated left ventricle | N | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Huntington disease pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Huntington's disease (05040) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |